Published in Anesthesiology on August 01, 1993
Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology (2008) 1.11
Effect of chemical permeation enhancers on nerve blockade. Mol Pharm (2009) 0.90
Effects of umbilical cord tissue mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration after neurotmesis injuries. J Stem Cells Regen Med (2014) 0.89
A bioengineered peripheral nerve construct using aligned peptide amphiphile nanofibers. Biomaterials (2014) 0.88
Multivesicular liposomal bupivacaine at the sciatic nerve. Biomaterials (2014) 0.88
Effects of collagen membranes enriched with in vitro-differentiated N1E-115 cells on rat sciatic nerve regeneration after end-to-end repair. J Neuroeng Rehabil (2010) 0.86
Functional recovery of completely denervated muscle: implications for innervation of tissue-engineered muscle. Tissue Eng Part A (2012) 0.85
Periaqueductal gray neuroplasticity following chronic morphine varies with age: role of oxidative stress. Neuroscience (2012) 0.82
Local toxicity from local anesthetic polymeric microparticles. Anesth Analg (2013) 0.80
Use of hybrid chitosan membranes and human mesenchymal stem cells from the Wharton jelly of umbilical cord for promoting nerve regeneration in an axonotmesis rat model. Neural Regen Res (2012) 0.80
A novel ropivacaine-loaded in situ forming implant prolongs the effect of local analgesia in rats. Arch Med Sci (2012) 0.79
Evaluation of biodegradable electric conductive tube-guides and mesenchymal stem cells. World J Stem Cells (2015) 0.79
Promoting nerve regeneration in a neurotmesis rat model using poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly: in vitro and in vivo analysis. Biomed Res Int (2014) 0.78
Rat sciatic nerve reconstruction across a 30 mm defect bridged by an oriented porous PHBV tube with Schwann cell as artificial nerve graft. ASAIO J (2014) 0.78
Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine. PLoS One (2015) 0.78
Thermoresponsive nanogels for prolonged duration local anesthesia. Acta Biomater (2012) 0.78
Efficacy of nanofibrous conduits in repair of long-segment sciatic nerve defects. Neural Regen Res (2013) 0.75
Two-Stage Nerve Graft in Severe Scar: A Time-Course Study in a Rat Model. Arch Bone Jt Surg (2015) 0.75
Tetrodotoxin, Epinephrine, and Chemical Permeation Enhancer Combinations in Peripheral Nerve Blockade. Anesth Analg (2017) 0.75
Drug delivery systems for prolonged duration local anesthesia. Mater Today (Kidlington) (2016) 0.75
Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46
The impact of conservation on the status of the world's vertebrates. Science (2010) 6.71
Functional arteries grown in vitro. Science (1999) 6.08
Barbiturates in the care of the terminally ill. N Engl J Med (1992) 5.42
Pain, euthanasia, and anesthesiologists. Anesthesiology (1993) 3.76
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
Effectiveness of laser therapy and topical desensitising agents in treating dentine hypersensitivity: a systematic review. J Oral Rehabil (2011) 2.91
New challenges in biomaterials. Science (1994) 2.85
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res (2000) 2.67
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
A controlled-release microchip. Nature (1999) 2.39
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet (2000) 2.39
Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27
Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy (2005) 2.23
Optimal pain relief in infants and children. BMJ (1993) 2.23
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07
Interactions of human nuclear proteins P1Mcm3 and P1Cdc46. Eur J Biochem (1995) 2.03
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99
Convulsions associated with pediatric regional anesthesia. Anesth Analg (1992) 1.98
Experimental reproduction of Potomac horse fever in horses with a newly isolated Ehrlichia organism. J Clin Microbiol (1985) 1.97
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci U S A (1994) 1.93
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am (1992) 1.89
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci (1980) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg (2001) 1.84
Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Identification of an inhibitor of neovascularization from cartilage. Science (1990) 1.78
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76
Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res (2001) 1.75
Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci (1995) 1.71
Local retinoid signaling coordinates forebrain and facial morphogenesis by maintaining FGF8 and SHH. Development (2001) 1.63
The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Exp Cell Res (1977) 1.60
Control of severe pain in children with terminal malignancy. J Pediatr (1995) 1.58
A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin. J Biol Chem (1984) 1.57
Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57
Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57
Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg (1988) 1.55
DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res (1998) 1.53
Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg (1999) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48
A cluster of microvillous inclusion disease in the Navajo population. J Pediatr (1999) 1.47
Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem (1998) 1.47
Pediatric motor vehicle related injuries in the Navajo Nation: the impact of the 1988 child occupant restraint laws. Inj Prev (2002) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Bacterial inactivation by using near- and supercritical carbon dioxide. Proc Natl Acad Sci U S A (1999) 1.43
Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem (1985) 1.43
Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42
Two consecutive hydrolethalus syndrome-affected pregnancies in a nonconsanguinous black couple: discussion of problems in prenatal differential diagnosis of midline malformation syndromes. Am J Med Genet (1993) 1.42
Diagnostic accuracy of simpson atherectomy catheter biopsy in detecting pancreaticobiliary malignancy. Am J Gastroenterol (2001) 1.42
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42
Protein stability in controlled-release systems. Nat Biotechnol (2000) 1.41
Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing system. J Pediatr (1996) 1.41
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
Responsive polymeric delivery systems. Adv Drug Deliv Rev (2001) 1.40
Dumbbell metastatic cystosarcoma phyllodes of the heart and lung. Ann Thorac Surg (1990) 1.39
Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A (1989) 1.39
Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials (2005) 1.38
Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37
Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart (2007) 1.36
Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol (1985) (1998) 1.36
Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology (1998) 1.36
Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells. Proc Natl Acad Sci U S A (1994) 1.33
Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res (1985) 1.33
Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet (1994) 1.32
Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol (2004) 1.32
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 1.31
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci (1995) 1.30
Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion. Nanotechnology (2005) 1.30